Skip to main content
SpringerLink
Log in
Book cover

New Concepts in the Pathogenesis of NIDDM pp 287–294Cite as

Hyperinsulinemia and VLDL Kinetics

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 334))

Abstract

The most frequent lipoprotein abnormality in diabetes mellitus is hypertriglyceridemia. The frequency of hypercholesterolemia is not very different from that found in the nondiabetic population.1,2 In those diabetic individuals who are grossly insulin deficient, the hypertriglyceridemia is due to an accumulation of chylomicrons, the primary transporters of dietary lipids. However, most diabetics, particularly those with NIDDM, do not have such severe insulin deficiency. In fact, as will be indicated below, many are hyperinsulinemic.3 In them the hypertriglyceridemia is due to an increased concentration of those triglyceride-rich lipoproteins that transport endogenous (i.e. nondietary) triglyceride. Such lipoproteins are generally called VLDL. However, they are in fact a population of lipoproteins that cover a wide spectrum of size and density. We have found, in nondiabetic individuals, that 75% of this population of lipoproteins is in the smaller, Sf 12–60 subpopulation of lipoproteins, a population also referred to as IDL.4 Based on kinetics considerations, this subpopulation in humans conforms to the characteristics of VLDL remnants.5 The remnant lipoproteins have been shown by many to be associated with an increased incidence of coronary artery disease.6–8

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Zimmerman BR, Palumbo PJ, O’Falion WA, et al. A prospective study of peripheral arterila occlusive disease in diabetics, III. Initial lipid and lipoprotein findings. Mayo Clin Proc. 56:223 (1981).

    PubMed  Google Scholar 

  2. Barrett-Connor E, Grundy SM, Holdbrook M.J. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol. 115: 657 (1982).

    PubMed  CAS  Google Scholar 

  3. Steiner G. Insulin regulation of triglyceride metabolism. Atherosclerosis Revs. 22:2 (1991).

    Google Scholar 

  4. Poapst M, Reardon M, Steiner G. Relative contribution of triglyceride-rich lipoprotein particle size and number to plasma triglyceride concentration. Arteriosclerosis 5:381 (1985).

    Article  PubMed  CAS  Google Scholar 

  5. Reardon MF, Steiner G. The use of kinetics in investigating metabolism of very low density and intermediate density lipoproteins in “Lipoprotein Kinetics and Modeling” Berman M, Grundy SM, Howard BV, eds. Academic Press, New York (1982).

    Google Scholar 

  6. Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 75:124 (1987).

    Article  PubMed  CAS  Google Scholar 

  7. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 71:881 (1985).

    Article  PubMed  CAS  Google Scholar 

  8. Krauss RM, Lindgren FT, Williams PT, et al. Intermediate density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet 11:62 (1987).

    Article  Google Scholar 

  9. Steiner G. Atherosclerosis, the major complication of diabetes, in “Comparison of Type I and Type II Diabetes.” Vranic M, Hollenberg CH, Steiner G, eds. Plenum Publishing Corp., Toronto, (1985).

    Google Scholar 

  10. Welborn TA, Wearn K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:131 (1979).

    Article  Google Scholar 

  11. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15 year follow-up. Diabetologia 34:356 (1991).

    Article  PubMed  CAS  Google Scholar 

  12. Pyorala K, Savolainen E, Kaukola S, et al. Plasma insulin as a coronary heart disease risk factor: Relationship to other risk factors and predictive value during 9 year follow-up of the Helsinki Policeman Study population. Acta Med Scand. 701(Suppl):38 (1985).

    CAS  Google Scholar 

  13. Ronnemaa T, Laakso M, Pyorala K, et al. High fasting plasma insulin is an indicator of coronary heart disease in noninsulin-dependent diabetic patients and nondiabetic subjects. Arterioscl. and Thromb. 11:80 (1991).

    Article  CAS  Google Scholar 

  14. Ronnemaa T, Laakso M, Puukla P, et al. Atherosclerotic cardiovascular disease in middle aged insulin treated diabetic patients. Association with endogenous insulin secretion capacity. Arteriosclerosis. 8:23 (1988).

    Google Scholar 

  15. Nagi D, Hendra TJ, Ryle AJ, et al. The relationships of concentrations of insulin, intact proinsulin and 23–33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33:532 (1990).

    Article  PubMed  CAS  Google Scholar 

  16. Streja DA, Marliss EB, Steiner G. The effects of prolonged fasting on plasma triglyceride kinetics in man. Metabolism 26:505 (1977).

    Article  PubMed  CAS  Google Scholar 

  17. Cattran DC, Steiner G, Wilson DR, Fenton SSA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Int Med. 91:554 (1979).

    PubMed  CAS  Google Scholar 

  18. Steiner G, Haynes FJ, Yoshino G, Vranic M. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am J Physiol 246:E187 (1984).

    PubMed  CAS  Google Scholar 

  19. Martin C, Desai KS, Steiner G. Receptor and post-receptor insulin resistance induced by in vivo hyperinsulinemia. Can J Physiol Pharmacol. 61:802 (1983).

    Article  PubMed  CAS  Google Scholar 

  20. Brubaker LP, Kazumi T, Hirano T, Vranic M, Steiner G. Failure of chronic hyperinsulinemia to supress pancreatic glucagon in vivo in the rat. Can J Physiol Pharmacol. 69:437 (1991).

    Article  PubMed  CAS  Google Scholar 

  21. Kazumi T, Vranic M, Bar-On H, Steiner G Portal v peripheral hyperinsulinemia and very low density lipoprotein triglyceride kinetics. Metabolism 35:1024 (1986).

    Article  PubMed  CAS  Google Scholar 

  22. Durrington PN, Newton RS, Weinstein DB, Steinberg D. Effects of insulin and glucose on very-low-density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest. 70:63 (1982).

    Article  PubMed  CAS  Google Scholar 

  23. Patsch W, Franz S, Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest. 71:1161 (1983).

    Article  PubMed  CAS  Google Scholar 

  24. Bartlett SM, Gibbons G.F. Short-and long-term regulation of very-low density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 249:37 (1988).

    PubMed  CAS  Google Scholar 

  25. Shumak SL, Zinman B, Zunig-Guarjardo S, Poapst M, Steiner G. Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans. Metabolism. 37:461 (1988).

    Article  PubMed  CAS  Google Scholar 

  26. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Acute hyperinsulinemia decreases very low density lipoprotein (VLDL) triglyceride and VLDL apolipoprotein (Apo) B production in normal weight but not in obese men. Diabetes. in press (1993).

    Google Scholar 

  27. Ferguson K, Mamo J, Steiner G. (in preparation).

    Google Scholar 

  28. Raman M, Steiner G. Effect of insulin on VLDL-triglyceride secretion and glucose production in the perfused rat liver. Diabetes 39(suppl 1):45A(1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Toronto General Division, The Toronto Hospital, Toronto, Ontario, Canada, M5G 2C4

    George Steiner

Authors
  1. George Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Karolinska Hospital, Stockholm, Sweden

    Claes Göran Östenson  & Suad Efendić  & 

  2. University of Toronto, Toronto, Ontario, Canada

    Mladen Vranic

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Steiner, G. (1993). Hyperinsulinemia and VLDL Kinetics. In: Östenson, C.G., Efendić, S., Vranic, M. (eds) New Concepts in the Pathogenesis of NIDDM. Advances in Experimental Medicine and Biology, vol 334. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2910-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2910-1_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6262-3

  • Online ISBN: 978-1-4615-2910-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation